Trials / Not Yet Recruiting
Not Yet RecruitingNCT06582563
Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Perosphere Technologies Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Whole blood clotting time measurements are to collect the clotting time ranges for DOAC-anticoagulated patients and assess their correlation with plasma drug levels (via anti-FXa assay).
Detailed description
Primary objectives of the planned whole blood clotting time measurements are to collect the clotting time ranges for DOAC-anticoagulated patients and assess their correlation with plasma drug levels (via anti-FXa assay).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Whole Blood Clotting Time | Comparator |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-07-30
- Completion
- 2025-08-30
- First posted
- 2024-09-03
- Last updated
- 2024-10-08
Locations
1 site across 1 country: Belgium
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06582563. Inclusion in this directory is not an endorsement.